News + Filings Holdings
|
TANG CAPITAL MANAGEMENT LLC
|
|
Changes: All | New | Increased | Decreased | Sold Out |
Portfolio as of: |
Name | Ticker | Class | Shares | Change | Value | Change | % Port | % OS | Hist | Date |
ImmunoGen, Inc.
| IMGN | COM | 1,300,000 | 25,147 | 24,531,000,000 | 18,207,729,000 | 3.61 | 0.58 |
Hist
| 06/30/2023 |
Evolus, Inc.
| EOLS | COM | 3,097,399 | 2,287,911 | 22,518,091,000 | 16,438,836,000 | 3.32 | 5.44 |
Hist
| 06/30/2023 |
Mirum Pharmaceuticals, Inc.
| MIRM | Common | 1,137,107 | 17,107 | 29,416,958,000 | 7,576,958,000 | 4.33 | 2.99 |
Hist
| 06/30/2023 |
ELI LILLY & Co
| LLY | Common | 30,000 | 10,000 | 14,069,400,000 | 6,752,600,000 | 2.07 | 0.00 |
Hist
| 06/30/2023 |
Zymeworks Inc.
| ZYME | Common | 1,100,000 | 700,000 | 9,504,000,000 | 6,360,000,000 | 1.40 | 1.71 |
Hist
| 06/30/2023 |
Intra-Cellular Therapies, Inc.
| ITCI | Common | 300,000 | 60,000 | 18,996,000,000 | 6,295,200,000 | 2.80 | |
Hist
| 06/30/2023 |
CytomX Therapeutics, Inc.
| CTMX | Common | 6,600,000 | 3,089,555 | 11,352,000,000 | 5,735,288,000 | 1.67 | 9.95 |
Hist
| 06/30/2023 |
Elevation Oncology, Inc.
| ELEV | COM | 4,000,000 | 3,520,146 | 6,080,000,000 | 5,624,139,000 | 0.90 | 16.44 |
Hist
| 06/30/2023 |
Bolt Biotherapeutics, Inc.
| BOLT | Common | 3,333,803 | 2,933,803 | 4,267,268,000 | 3,747,268,000 | 0.63 | 8.82 |
Hist
| 06/30/2023 |
PARDES BIOSCIENCES, INC.
| PRDS | Common | 1,945,206 | 1,911,458 | 3,520,823,000 | 3,463,789,000 | 0.52 | 3.15 |
Hist
| 06/30/2023 |
LianBio
| LIAN | SPONSORED ADS | 962,022 | 902,422 | 2,193,410,000 | 2,095,666,000 | 0.32 | |
Hist
| 06/30/2023 |
Graphite Bio, Inc.
| GRPH | Common | 2,085,625 | 985,625 | 5,422,625,000 | 1,770,625,000 | 0.80 | 3.59 |
Hist
| 06/30/2023 |
Third Harmonic Bio, Inc.
| THRD | Common | 1,800,000 | 100,000 | 8,658,000,000 | 1,348,000,000 | 1.27 | 4.46 |
Hist
| 06/30/2023 |
Arvinas, Inc.
| ARVN | Common | 80,000 | 50,000 | 1,985,600,000 | 959,300,000 | 0.29 | |
Hist
| 06/30/2023 |
Coherus BioSciences, Inc.
| CHRS | Common | 400,000 | 284,100 | 1,708,000,000 | 790,072,000 | 0.25 | 0.50 |
Hist
| 06/30/2023 |
CRISPR Therapeutics AG
| CRSP | Common | 20,000 | 10,000 | 1,122,800,000 | 716,300,000 | 0.17 | 0.03 |
Hist
| 06/30/2023 |
Adicet Bio, Inc.
| ACET | Common | 2,479,552 | 1,879,552 | 6,025,311,000 | 661,311,000 | 0.89 | 5.77 |
Hist
| 06/30/2023 |
BIOCRYST PHARMACEUTICALS INC
| BCRX | Common | 2,450,000 | 1,000,000 | 17,248,000,000 | 602,000,000 | 2.54 | 1.30 |
Hist
| 06/30/2023 |
Aligos Therapeutics, Inc.
| ALGS | Common | 3,329,048 | 512,657 | 3,232,506,000 | 548,767,000 | 0.48 | 7.75 |
Hist
| 06/30/2023 |
Mirati Therapeutics, Inc.
| MRTX | COM | 80,000 | 20,000 | 2,890,400,000 | 171,800,000 | 0.43 | 0.14 |
Hist
| 06/30/2023 |
MOLECULAR PARTNERS AG
| MOLN | Common | 39,753 | 17,753 | 247,264,000 | 103,164,000 | 0.04 | |
Hist
| 06/30/2023 |
Life Technologies Corp
| LIFE | COMMON | 150,000 | 26,570 | 324,000,000 | 53,688,000 | 0.05 | |
Hist
| 06/30/2023 |
Genfit S.A.
| GNFT | Common | 1,234,436 | 36,914 | 4,369,903,000 | -886,021,000 | 0.64 | |
Hist
| 06/30/2023 |
bluebird bio, Inc.
| BLUE | Common | 7,382,827 | 2,747,299 | 24,289,501,000 | -7,788,353,000 | 3.58 | 6.94 |
Hist
| 06/30/2023 |
BioAtla, Inc.
| BCAB | Common | 3,674,076 | 550,000 | 11,022,228,000 | -14,751,399,000 | 1.62 | 7.71 |
Hist
| 06/30/2023 |
Altimmune, Inc.
| ALT | COM NEW | 2,750,000 | 49,550 | 9,707,500,000 | -34,714,903,000 | 1.43 | 5.58 |
Hist
| 06/30/2023 |
|
|
|
|